BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Treatment
1260 results:

  • 1. cancer diagnosis after emergency presentations in people with mental health and substance use conditions: a national cohort study.
    Cunningham R; Stanley J; Imlach F; Haitana T; Lockett H; Every-Palmer S; Clark MTR; Lacey C; Telfer K; Peterson D
    BMC Cancer; 2024 Apr; 24(1):546. PubMed ID: 38689242
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of combined pulmonary fibrosis and emphysema on lung cancer risk and mortality in rheumatoid arthritis: A multicenter retrospective cohort study.
    Mori S; Ueki Y; Hasegawa M; Nakamura K; Nakashima K; Hidaka T; Ishii K; Kobayashi H; Miyamura T
    PLoS One; 2024; 19(2):e0298573. PubMed ID: 38412181
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparative Analysis of Skip Metastasis in Pediatric Osteosarcoma: Clinical Features and Outcomes.
    Halalsheh H; Amer S; Omari Z; Shawagfeh M; Boheisi M; Sultan I
    J Pediatr Hematol Oncol; 2024 Apr; 46(3):154-158. PubMed ID: 38408127
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Discovery of WS-384, a first-in-class dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor for the treatment of non-small cell lung cancer.
    Li A; Ma T; Wang S; Guo Y; Song Q; Liu H; Yu B; Feng S
    Biomed Pharmacother; 2024 Apr; 173():116240. PubMed ID: 38401512
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
    Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Enhanced Sensitivity of A549 Cells to Doxorubicin with WS
    Jin W; Yang T; Jia J; Jia J; Zhou X
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256235
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status.
    Anakha J; Dobariya P; Sharma SS; Pande AH
    Med Oncol; 2023 Dec; 41(1):24. PubMed ID: 38123873
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Use of Quantitative CT Imaging to Identify Bronchial Thermoplasty Responders.
    Samant M; Krings JG; Lew D; Goss CW; Koch T; McGregor MC; Boomer J; Hall CS; Schechtman KB; Sheshadri A; Peterson S; Erzurum S; DePew Z; Morrow LE; Hogarth DK; Tejedor R; Trevor J; Wechsler ME; Sam A; Shi X; Choi J; Castro M
    Chest; 2024 Apr; 165(4):775-784. PubMed ID: 38123124
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multimodality local consolidative treatment versus conventional care of advanced lung cancer after first-line systemic anti-cancer treatment: study protocol for the RAMON multicentre randomised controlled trial with an internal pilot.
    Beard C; Rogers CA; Fleming L; Conibear J; Evison M; Newsom-Davis T; Barwick T; Mills N; Stokes EA; De Sousa P; Batchelor T; Rawlinson J; Baos S; Harris R; Lim E
    BMJ Open; 2023 Dec; 13(12):e081650. PubMed ID: 38072470
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Staging by Thoracoscopy in potentially radically treatable lung cancer associated with Minimal Pleural Effusion (STRATIFY): protocol of a prospective, multicentre, observational study.
    Ferguson J; Tsim S; Kelly C; Alexander L; Shad S; Neilly M; Tate M; Zahra B; Saleh M; Cowell G; Banks E; Grundy S; Corcoran J; Downer N; Stanton A; Evison M; Rahman NM; Maskell N; Blyth KG
    BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37996118
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Trends in lung cancer diagnosis and care among visible minorities and non-visible minorities in Canada.
    McFadgen H; Lethbridge L; Dunbar M; Plourde M
    Cancer Causes Control; 2024 Apr; 35(4):575-582. PubMed ID: 37932475
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. SABR for Sarcoma lung Metastases: Indications for treatment and Guidance for Patient Selection.
    Farooqi AS; Yoder AK; Lin HY; Pasalic D; Erasmus J; Betancourt S; Wernz C; Mitra D; Zarzour MA; Somaiah N; Conley A; Ratan R; Livingston A; Araujo DM; Roland C; Scally C; Keung E; Gandhi SN; Ashleigh Guadagnolo B; Nguyen QN; Bishop AJ
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):971-978. PubMed ID: 37914142
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Association of census-tract level gentrification and income inequality with 6-year incidence of metabolic syndrome in the Hispanic Community Health Study/Study of Latinos, an epidemiologic cohort study.
    Pichardo CM; Chambers EC; Sanchez-Johnsen LAP; Pichardo MS; Gallo L; Talavera GA; Pirzada A; Roy A; Castañeda SF; Durazo-Arvizu RA; Perreira KM; Teng Y; Rodriguez CB; Allison M; Carlson JA; Daviglus ML; Plascak JJ
    Soc Sci Med; 2023 Nov; 336():116222. PubMed ID: 37776783
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Association of socioeconomic factors with the receipt of neoadjuvant therapy for patients with non-small cell lung cancer.
    Elbahrawy MM; Kamel MK; Rodriguez-Quintero JH; Vimolratana M; Chudgar NP; Stiles BM
    J Thorac Cardiovasc Surg; 2024 Apr; 167(4):1458-1466.e4. PubMed ID: 37741315
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation.
    Emerging Risk Factors Collaboration
    Lancet Diabetes Endocrinol; 2023 Oct; 11(10):731-742. PubMed ID: 37708900
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Bidirectional Association Between Cardiovascular Disease and lung cancer in a Prospective Cohort Study.
    Zhang S; Liu L; Shi S; He H; Shen Q; Wang H; Qin S; Chang J; Zhong R
    J Thorac Oncol; 2024 Jan; 19(1):80-93. PubMed ID: 37703998
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an eln-DAVID expert panel.
    Ravandi F; Cloos J; Buccisano F; Dillon R; Döhner K; Freeman SD; Hourigan CS; Ossenkoppele GJ; Roboz GJ; Subklewe M; Thiede C; Arnhardt I; Valk PJM; Venditti A; Wei AH; Walter RB; Heuser M
    Am J Hematol; 2023 Dec; 98(12):1847-1855. PubMed ID: 37671649
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Progression before local control in osteosarcoma: Outcome and prognosis-predictive factors.
    Halalsheh H; Amer S; Sultan I
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30649. PubMed ID: 37638816
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. cancer in Victorian prisoners: a description of cancer diagnoses, demographics, risk factors and barriers to optimal care.
    Newnham GM; Munton K; Shaw M; McLachlan SA
    Intern Med J; 2024 Feb; 54(2):295-300. PubMed ID: 37540770
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The gold standard program (GSP) for smoking cessation: a cohort study of its effectiveness among smokers with and without cancer.
    Lauridsen SV; Jensen BT; Tønnesen H; Dalton SO; Rasmussen M
    Acta Oncol; 2023 Jul; 62(7):774-781. PubMed ID: 37405937
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 63.